SUMMARY Anti-DNA antibodies have been detected previously in patients with chronic discoid lupus erythematosus (DLE) despite the absence of overt systemic manifestations. 27 patients with DLE were followed up 3 years after the detection of anti-DNA antibodies in 7. None had developed other features of systemic lupus erythematosus. We conclude that the occasional finding of anti-DNA antibodies in patients with DLE does not predict those likely to develop systemic disease.
The detection of serum anti-DNA antibodies is an important adjunct to the investigation and management of patients with systemic lupus erythematosus (SLE) (Hughes, 1971) . In the absence of systemic disease, patients with chronic discoid lupus erythematosus (DLE) usually do not have anti-DNA antibodies (Prystowsky et al., 1976) . However, some studies using sensitive techniques have reported the presence of anti-DNA antibodies in a proportion of patients with DLE (Mandel etal., 1972; Sylvester et al., 1973) , but the clinical significance of this finding has not been established. A previous study from this unit included 42 patients with DLE of whom 15 also had systemic disease (Davis et al., 1974) . All patients with SLE had raised levels of anti-DNA antibody. Sera from 7 of 27 patients with DLE and no systemic features contained anti-DNA antibodies. As about 5% of patients with SLE present with discoid lesions, it was suggested that the finding of anti-DNA antibodies in patients with DLE (Davis et al., 1974) . Information on the clinical course during the subsequent 3 years was available in 24; 3 patients could not be traced. 6 patients originally had anti-DNA antibodies, while 18 did not. The majority were seen and examined by one of us (B.B.), and serum was obtained. In 7 cases clinical information and serum samples were provided by other attending physicians.
As in the original study, anti-DNA antibodies were assayed by ammonium sulphate precipitation (Wold et al., 1968 (Tuffanelli et al., 1969; Dubois, 1974; Prystowsky and Gilliam, 1975) . While most patients with discoid lesions have disease that remains confined to the skin, about 14% of patients with SLE will manifest discoid lesions during the course of their diseases (Estes and Christian, 1971 ). Some patients with DLE develop antinuclear antibodies (Rothfield et al., 1963; Shrank and Doniach, 1963; Beck and Rowell, 1966; Burnham and Bank, 1974) , but this feature appears to bear no relationship to the course ofthe disease. The observation that some patients with DLE were found to have anti-DNA antibodies suggested that this might be a means of predicting those likely to develop extracutaneous manifestations. Our study was undertaken to investigate that possibility. The results show that none of the patients previously found by Davis et al. (1974) 
